PDX model details
PDX ID
275R
Host Strain(and Source)
NSG Source: Monash University
Host Strain Immune system Humanized
NO
Host Type
Testosterone supplemented
Graft Site
Subcutaneous
Current Generation (* indicates number of generations grown in Castrate host)
18
Average PDX Generation Time (days +/- SEM)
99 ± 9
Tumor preparation
Tumor solid
Tumor Characterization Technology
Histology, IHC, STR profiling, targeted DNA sequencing, RNAseq
Tumor confirmed not to be of Mouse/EBV origin
Yes; negative for CD45 and/or positive for human CK8/18 and/or human mitochondria by IHC
Passage QA performed
Routine QA every 2-3 passages
Associated meta data
PDX model availability
Yes (fixed, frozen)
Governance restriction for distribution
Available to investigators with appropriate ethics approvals, approved EOI from MURAL committee, and material transfer agreements
Pubmed ID
34413304
Markers
275R
AR
Y
PSA
Y
PSMA
Y
NE
N
ERG
Y
This heatmap displays the call type of curated CNVs in the presented samples.
This heatmap displays the call type of CNVs in commonly occurred samples.
This table displays curated CNVs
PDX ID
Gene Symbol
CNV Log2
CNV Copy
CNV Call
Experiments name
Platform
Reference genome
275R
CHD7
0.87599
3.67053
gain
MURAL Prostate Cancer PDX collection
Targeted GARVAN Panel
hg19
275R
CHD7
0.548925
2.92599
gain
MURAL Prostate Cancer PDX collection
Targeted GARVAN Panel
hg19
275R
MYC
0.525896
2.87966
gain
MURAL Prostate Cancer PDX collection
Targeted GARVAN Panel
hg19
275R
RB1
-0.931422
1.04868
loss
MURAL Prostate Cancer PDX collection
Targeted GARVAN Panel
hg19
275R
TP53
-1.02398
0.983516
loss
MURAL Prostate Cancer PDX collection
Targeted GARVAN Panel
hg19
275R
TP53
-0.792427
1.15474
loss
MURAL Prostate Cancer PDX collection
Targeted GARVAN Panel
hg19
Clinical Information
Sample Number
275R
Sample Site
Prostate
Sample source
Radical prostatectomy
Pathology Tumor Diagnosis
Adenocarcinoma
Gleason Score
7
Primary Gleason Score
4
Secondary Gleason Score
3
Tertiary Gleason Score
None
ISUP Grade Group
3
Tumor Grade
pT3bN0
D'Amico Risk Classification
8
Tumor Volume (in cc)
3.2
Treatment Prior to Specimen Collection
None
Patient Information
Patient Number
275
Sex
Male
Diagnosis
Prostate Cancer
PSA at diagnosis (ng/mL)
45
Consent to share data
This heatmap displays the mutations of curated sequence variants.
Download
This table displays curated sequence variants
The table can be sorted by any field. However, please note that when you click on a column header to sort, there might be a brief delay
PDX ID
Gene Symbol
Depth
ALT_FREQ
Consequence
Exon
GnomAD_AF
CADD_PHRED
Clinvar_clnsig
Platform
Experiments Name
Reference
Library Type
Instrument Type
275R
TH
145
0.54
missense_variant
'4/14
7.90E-05
21.3
Uncertain_significance
Targeted GARVAN Panel
MURAL Prostate Cancer PDX collection
hg19
paired
Illumina HiSeq 2500
275R
AKT1
1657
0.49
missense_variant
'10/13
.
29
-
Targeted GARVAN Panel
MURAL Prostate Cancer PDX collection
hg19
paired
Illumina HiSeq 2500
275R
MITF
559
0.48
missense_variant
'9/10
1.63E-05
31
-
Targeted GARVAN Panel
MURAL Prostate Cancer PDX collection
hg19
paired
Illumina HiSeq 2500
275R
BRCA1
988
0.47
missense_variant
'10/24
0.0002358
12.77
Benign
Targeted GARVAN Panel
MURAL Prostate Cancer PDX collection
hg19
paired
Illumina HiSeq 2500
275R
ZNF717
33
0.36
stop_lost
'5/5
.
0.964
-
Targeted GARVAN Panel
MURAL Prostate Cancer PDX collection
hg19
paired
Illumina HiSeq 2500
275R
ZNF717
33
0.36
stop_lost
'5/5
.
0.964
-
Targeted GARVAN Panel
MURAL Prostate Cancer PDX collection
hg19
paired
Illumina HiSeq 2500
275R
ZNF717
60
0.32
stop_gained
'5/5
.
23.7
-
Targeted GARVAN Panel
MURAL Prostate Cancer PDX collection
hg19
paired
Illumina HiSeq 2500
275R
ZNF717
60
0.32
stop_gained
'5/5
.
23.7
-
Targeted GARVAN Panel
MURAL Prostate Cancer PDX collection
hg19
paired
Illumina HiSeq 2500
No information in Drug dosing Table